FGBI
First Guaranty Bancshares, Inc.
There isn't enough reported data to score FGBI yet.
MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
FGBI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| N/A | |
| N/A |
FGBI's revenue is currently stable, but its profitability is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like FGBI.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
FGBI PE Valuation
FGBI has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 23x next year's earnings.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
FGBI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect FGBI to return to profit, with revenue growing.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
FGBI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.57 | — |
| Q2 2026 | -$2.57 | -$1.56 |
| Q1 2026 | -$3.35 | -2677% |
| Q4 2025 | -$4.03 | -598% |
| Q3 2025 | -$4.13 | -592% |
| Q2 2025 | -$1.01 | -222% |
| Q1 2025 | $0.13 | -73% |
| Q4 2024 | $0.81 | +31% |
| Q3 2024 | $0.84 | -14% |
FGBI lost $2.57 per share over the past year, a bigger loss than the year before.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over FGBI on earnings quality, reporting a profit while its opponent remains loss making.
FGBI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $24.2M | -0.9% |
| Q1 2026 | $22.9M | -6.8% |
| Q4 2025 | $22.3M | -11% |
| Q3 2025 | $24.1M | -11% |
| Q2 2025 | $24.4M | -34% |
| Q1 2025 | $24.6M | +1.4% |
| Q4 2024 | $25.1M | +6.2% |
| Q3 2024 | $27.1M | +18% |
FGBI's revenue has slid since its 2024 peak: $24M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 18% | +57 points |
| Q1 2026 | 15% | +48 points |
| Q4 2025 | 13% | +8.4 points |
| Q3 2025 | -224% | -233 points |
| Q2 2025 | -39% | -64 points |
| Q1 2025 | -33% | -45 points |
| Q4 2024 | 4.7% | -2.2 points |
| Q3 2024 | 9.2% | -0.9 points |
FGBI's operating margin was 18% last quarter, up 57 points from the same quarter a year ago.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over FGBI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over FGBI on profitability, with a higher operating margin.
FGBI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$15.4M | +$3.2M |
| Q1 2026 | $50.4M | +873% |
| Q4 2025 | -$25.3M | -235% |
| Q3 2025 | $28.7M | +476% |
| Q2 2025 | -$18.6M | -381% |
| Q1 2025 | $5.2M | +1208% |
| Q4 2024 | $18.7M | +198% |
| Q3 2024 | $5M | +$11.8M |
FGBI has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
FGBI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.4% | +530K shares |
| 1 year | +26% | +3.4M shares |
| 3 years | +50% | +5.4M shares |
| 5 years | +52% | +5.6M shares |
| Available history | +53% | +5.7M shares |
FGBI has 16M diluted shares, up 26% from a year ago.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over FGBI on shareholder dilution, with a more favorable share count trend.
FGBI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2025 | -63.2x | Net Cash |
| Q4 2024 | -17.7x | Net Cash |
| Q3 2024 | -16.8x | Net Cash |
| Q2 2024 | -13.8x | Net Cash |
| Q1 2024 | -21.8x | Net Cash |
| Q4 2023 | -0.7x | Net Cash |
| Q3 2023 | -8.7x | Net Cash |
| Q2 2023 | -4.4x | Net Cash |
FGBI has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like FGBI.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
FGBI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 73.6 | Overbought |
| Stochastic | 90.4 | Overbought |
FGBI's weekly RSI is 74 (overbought) and its Stochastic is 90 (overbought).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
FGBI PE vs Financial Services Sector
| Metric | FGBI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
FGBI has no meaningful PE right now: it lost money over the past year.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
FGBI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.51 | 36% above |
| 20 week MA | $9.27 | 39% above |
| 50 week MA | $8.75 | 48% above |
| 100 week MA | $8.66 | 49% above |
| 200 week MA | $10.4 | 24% above |
FGBI has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
FGBI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.8 | $16.5 | -16% |
| 2021 | $16.5 | $20.7 | +25% |
| 2022 | $20.7 | $23.9 | +16% |
| 2023 | $23.9 | $11.1 | -53% |
| 2024 | $11.1 | $11.5 | +3.1% |
| 2025 | $11.5 | $5.03 | -56% |
| 2026 YTD | $5.03 | $12.9 | +157% |
FGBI has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.